Metraipolis › archive › dc_ca6ecbff5538
Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary — Europe PMC PMID:41266114
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41266114
- DOI
- 10.1136/jme-2025-111111
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T09:18:44.244Z
- SHA-256 of the archived text
2029fa6f465a658fe562739e9c36606e8a53b33287377c39f09e10420263f4df- Stable URL of this page
https://metraipolis.com/documento/dc_ca6ecbff5538
How to cite
Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary — Europe PMC PMID:41266114 — Europe PMC (en), https://europepmc.org/article/MED/41266114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca6ecbff5538 (Metraipolis archive dc_ca6ecbff5538, sha256 2029fa6f465a658fe562739e9c36606e8a53b33287377c39f09e10420263f4df)
BibTeX
@misc{dcca6ecbff5538,
title = {Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary — Europe PMC PMID:41266114},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41266114},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca6ecbff5538; sha256 2029fa6f465a658fe562739e9c36606e8a53b33287377c39f09e10420263f4df},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41266114. Agents can read the archived copy with the MCP tool read_document.